AI-powered
podcast player
Listen to all your favourite podcasts with AI-powered features
2min chapter
Obesity Medications
JAMA Clinical Reviews
Comparing Terzepatide to Semaglutide and Future of Weight Loss Drugs
This chapter explores the weight loss effectiveness of terzepatide, a dual agonist, when compared to semaglutide. It highlights the potential of dual agonists and Triagonists in enhancing weight loss outcomes, along with the development of oral small molecules mimicking the effects of GOP-1 for future weight loss drug advancements.
00:00
Transcript
Episode notes
Get the Snipd
podcast app
Unlock the knowledge in podcasts with the podcast player of the future.
AI-powered
Discover
highlights
Listen to the best highlights from the podcasts you love and dive into the full episode
Save any
moment
Hear something you like? Tap your headphones to save it with AI-generated key takeaways
Share
& Export
Send highlights to Twitter, WhatsApp or export them to Notion, Readwise & more
AI-powered
podcast player
Listen to all your favourite podcasts with AI-powered features
Discover
highlights
Listen to the best highlights from the podcasts you love and dive into the full episode